Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902219-17-000596
Filing Date
2017-11-13
Accepted
2017-11-13 10:04:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G 35601
  Complete submission text file 0000902219-17-000596.txt   37563
Mailing Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210
Business Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

IRS No.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 81 HARTWELL AVE. SUITE 100 LEXINGTON MA 02421
Business Address 81 HARTWELL AVE. SUITE 100 LEXINGTON MA 02421 646-522-8445
Nightstar Therapeutics plc (Subject) CIK: 0001711675 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90131 | Film No.: 171193808
SIC: 2836 Biological Products, (No Diagnostic Substances)